We are live on ! Find out more
FFVM

Founders Fund V Management Portfolio holdings

AUM $2.16M
1-Year Est. Return 77.37%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+77.37%
3 Year Est. Return
+859.57%
5 Year Est. Return
-74.2%
10 Year Est. Return
–
AUM
$947K
AUM Growth
+$144K
Cap. Flow
+$45.6K
Cap. Flow %
4.82%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
+$613K

Top Sells

Rank Stock Value
1
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
+$567K

Sector Composition

Rank Sector Weight
1 Healthcare 90.78%
2 Technology 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTH
1
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$764K 80.75%
+480,708
New +$613K
UBX
2
DELISTED
Unity Biotechnology
UBX
$94.9K 10.03%
49,172
– –
RGTI icon
3
Rigetti Computing
RGTI
$4.94B
$87.3K 9.22%
88,621
– –
AMTI
4
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
– –
-3,611,615
Closed -$567K

Similar funds

NA
Newport Asia San Francisco, California $2.21M AUM
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return

Founders Fund V Management's Q4 2023 Portfolio in Review

As of Q4 2023, Founders Fund V Management held 4 positions worth $947K, up 18% from $803K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund V Management deployed $45.6K of net new capital in Q4 2023, opening 1 new position. Its largest new stake was Cyclo Therapeutics, Inc. Common Stock: 480,708 shares worth $764K.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 85% a quarter earlier, followed by Technology.

On the sell side, the most notable exit was Applied Molecular Transport Inc. Common Stock, an estimated $567K sold.

  • Founders Fund V Management's largest Q4 2023 buy was Cyclo Therapeutics, Inc. Common Stock: 480,708 shares worth $764K.
  • Founders Fund V Management fully exited Applied Molecular Transport Inc. Common Stock in Q4 2023, selling an estimated $567K.
  • Founders Fund V Management's ten largest holdings make up 100% of its $947K portfolio in Q4 2023.
  • Founders Fund V Management opened 1 new position and closed 1 in Q4 2023.
  • Founders Fund V Management's portfolio value rose 18% quarter-over-quarter to $947K.

Based on Founders Fund V Management's 13F filing for Q4 2023, filed 14 Feb 2024.